What can we learn from animal models of alopecia areata?

Dermatology

Volumn 211, Issue 1, 2005, Pages 47-53

  McElwee, Kevin J ^a   Yu, Mei ^a   Park, Sung Wook ^a   Ross, Elizabeth K ^a   Finner, Andreas ^a   Shapiro, Jerry ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Animal models; Autoimmune diseases; Hair loss; Inflammation

Indexed keywords

ALOPECIA AREATA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOCHEMISTRY; CELL TYPE; GENETICS; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; IMMUNE SYSTEM; MELANOCYTE; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

ALOPECIA AREATA; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE;

EID: 21344468115     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085580     Document Type: Review

References (67)

1. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd: Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995;70:628-633.
2. Muller SA, Winkelmann RK: Alopecia areata: An evaluation of 736 patients. Arch Dermatol 1963;88:290-297.
3. Robinson T: Baldness and Greyness, Their Etiology, Pathology and Treatment, ed 2. London, Kimpton, 1883.
4. McElwee KJ, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP: Alopecia areata: An autoimmune disease? Exp Dermatol 1999;8:371-379.
5. Duckworth D: Case of area Celsi (porrigo decalvans), in which the parts were examined after death. Trans Pathol Soc 1882;33:386-392.
6. Giovannini S: Recherches sur l'histologic pathologique de la pelade. Ann Dermatol Syphiligr 1891;3:921-957.
7. Van Scott EJ: Morphologic changes in pilosebaceous units and anagen hairs in alopecia areata. J Invest Dermatol 1958;31:35-43.
8. Randall VA: Is alopecia areata an autoimmune disease? Lancet 2001;358:1922-1924.
9. McDonagh AJ, Messenger AG: Alopecia areata. Clin Dermatol 2001;19:141-147.
10. McElwee KJ, Hoffmann R: Alopecia areata - Animal models. Clin Exp Dermatol 2002;27:410-417.
11. Paus R, Slominski A, Czarnetzki BM: Is alopecia areata an autoimmune response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 1993;66:541-554.
12. Rose NR, Bona C: Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993;14:426-430.
13. Perret C, Wiesner-Menzel L, Happle R: Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venereol 1984;64:26-30.
14. Ranki A, Kianto U, Kanerva L, Tolvanen E, Johansson E: Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis). J Invest Dermatol 1984;83:7-11.
15. Wiesner-Menzel L, Happle R: Intrabulbar and peribulbar accumulation of dendritic OKT 6-positive cells in alopecia areata. Arch Dermatol Res 1984;276:333-334.
16. Hoffmann R, Wenzel E, Huth A, van der Steen P, Schaufele M, Henninger HP, Happle R: Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 1994;103:530-533.
17. Tang L, Cao L, Bernardo O, Chen Y, Sundberg JP, Lui H, Chung S, Shapiro J: Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with an alopecia areata-like disease by targeting infiltrated lymphocytes. J Invest Dermatol 2003;120:400-406.
18. Tang L, Cao L, Sundberg JP, Lui H, Shapiro J: Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. Exp Dermatol 2004;13:5-10.
19. Freyschmidt-Paul P, Hoffmann R, Levine E, Sundberg JP, Happle R, McElwee KJ: Current and potential agents for the treatment of alopecia areata. Curr Pharm Des 2001;7:213-230.
20. Mcdonagh AJ, Snowden JA, Stierle C, Elliott K, Messenger AG: HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: The role of cytokines. Br J Dermatol 1993;129:250-256.
21. de Andrade M, Jackow CM, Dahm N, Hordinsky M, Reveille JD, Duvic M: Alopecia areata in families: Association with the HLA locus. J Invest Dermatol Symp Proc 1999;4:220-223.
22. Colombe BW, Lou CD, Price VH: The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J Invest Dermatol Symp Proc 1999;4:216-219.
23. Barahmani N, Whaley K, Duvic M: Alopecia areata after allogeneic bone marrow transplantation from an affected, human leukocyte antigen-matched sibling. J Am Acad Dermatol 2003;49:1192.
24. Sanli H, Kusak F, Arat M, Ekmekci P, Ilhan O: Simultaneous onset of chronic graft versus host disease and alopecia areata following allogeneic haematopoietic cell transplantation. Acta Derm Venereol 2004;84:86-87.
25. Morel L: Mouse models of human autoimmune diseases: Essential tools that require the proper controls. Plos Biol 2004;2:E241.
26. Gilhar A, Krueger GG: Hair growth in scalp grafts from patients with alopecia areata and alopecia universalis grafted onto nude mice. Arch Dermatol 1987;123:44-50.
27. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS: Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 1998;101:62-67.
28. Tobin DJ, Gardner SH, Luther PB, Dunston SM, Lindsey NJ, Olivry T: A natural canine homologue of alopecia areata in humans. Br J Dermatol 2003;149:938-950.
29. Tobin DJ, Alhaidari Z, Olivry T: Equine alopecia areata autoantibodies target multiple hair follicle antigens and may alter hair growth: A preliminary study. Exp Dermatol 1998;7:289-297.
30. McElwee KJ, Boggess D, Olivry T, Oliver RF, Whiting D, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP: Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology 1998;66:90-107.
31. McElwee KJ, Boggess D, Miller J, King LE Jr, Sundberg JP: Spontaneous alopecia areata-like hair loss in one congenic and seven inbred laboratory mouse strains. J Invest Dermatol Symp Proc 1999;4:202-206.
32. Smyth JR Jr, McNeil M: Alopecia areata and universalis in the Smyth chicken model for spontaneous autoimmune vitiligo. J Invest Dermatol Symp Proc 1999;4:211-215.
33. Michie HJ, Jahoda CA, Oliver RF, Johnson BE: The DEBR rat: An animal model of human alopecia areata. Br J Dermatol 1991;125:94-100.
34. Michie HJ, Jahoda CA, Oliver RF, Poulton TA: Immunobiological studies on the alopecic (DEBR) rat. Br J Dermatol 1990;123:557-567.
35. Zhang JG, Oliver RF: Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata. Br J Dermatol 1994;130:405-414.
36. McElwee KJ, Pickett P, Oliver RF: The DEBR rat, alopecia areata and autoantibodies to the hair follicle. Br J Dermatol 1996;134:55-63.
37. Sundberg JP, Cordy WR, King LE Jr: Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 1994;102:847-856.
38. McElwee KJ, Silva K, Boggess D, Bechtold L, King LE Jr, Sundberg JP: Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss. Vet Pathol 2003;40:643-650.
39. McElwee KJ, Boggess D, King LE Jr, Sundberg JP: Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 1998;111:797-803.
40. Carroll JM, McElwee KJ, King LE, Byrne MC, Sundberg JP: Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol 2002;119:392-402.
41. McElwee KJ, Hoffmann R, Freyschmidt-Paul P, Wenzel E, Kissling S, Sundberg JP, Zöller M: Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells. J Invest Dermatol 2002;119:1426-1433.
42. Zöller M, McElwee KJ, Engel P, Hoffmann R: Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol 2002;118:983-992.
43. McElwee KJ, Spiers EM, Oliver RF: In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata. Br J Dermatol 1996;135:211-217.
44. McElwee KJ, Spiers EM, Oliver RF: Partial restoration of hair growth in the DEBR model for alopecia areata after in vivo depletion of CD4+ T cells. Br J Dermatol 1999;140:432-437.
45. Freyschmidt-Paul P, Seiter S, Zoller M, Konig A, Ziegler A, Sundberg JP, Happle R, Hoffmann R: Treatment with an anti-CD44v10-specific antibody inhibits the onset of alopecia areata in C3H/HeJ mice. J Invest Dermatol 2000;115:653-657.
46. McElwee KJ, Freyschmidt-Paul P, Hoffmann R, Kissling S, Hummel S, Vitacolonna M, Zöller M: Transfer of CD8 cells induces localized hair loss whereas CD4/CD25 cells promote systemic alopecia areata and CD4/CD25 cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol 2005;124:947-957.
47. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, Morris PJ, Powrie F, Wood KJ: IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166:3789-3796.
48. Kumanogoh A, Wang X, Lee I, Watanabe C, Kamanaka M, Shi W, Yoshida K, Sato T, Habu S, Itoh M, Sakaguchi N, Sakaguchi S, Kikutani H: Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: A role of CD40 in regulatory T cell development. J Immunol 2001;166:353-360.
49. Zöller M, McElwee KJ, Vitacolonna M, Hoffmann R: Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients. J Autoimmun 2004;23:241-256.
50. Zöller M, McElwee KJ, Vitacolonna M, Hoffmann R: The progressive state, in contrast to the stable or regressive state of alopecia areata, is reflected in peripheral blood mononuclear cells. Exp Dermatol 2004;13:435-444.
51. Huber S, Schramm C, Lehr HA, Mann A, Schmitt S, Becker C, Protschka M, Galle PR, Neurath MF, Blessing M: Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 2004;173:6526-6531.
52. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, Masteller EL, McDevitt H, Bonyhadi M, Bluestone JA: In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004;199:1455-1465.
53. Walker MR, Carson BD, Nepom GT, Ziegler SF, Buckner JH: De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc Natl Acad Sci USA 2005;102:4103-4108.
54. Freyschmidt-Paul P, McElwee KJ, Botchkarev V, Kissling S, Wenzel E, Sundberg JP, Happle R, Hoffmann R: Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice. J Invest Dermatol Symp Proc 2003;8:104-108.
55. McElwee KJ, Freyschmidt-Paul P, Zoller M, Hoffmann R: Alopecia areata susceptibility in rodent models. J Invest Dermatol Symp Proc 2003;8:182-187.
56. Sundberg JP, Boggess D, Silva KA, McElwee KJ, King LE, Li R, Churchill G, Cox GA: Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol 2003;120:771-775.
57. McElwee KJ, Niiyama S, Freyschmidt-Paul P, Wenzel E, Kissling S, Sundberg JP, Hoffmann R: Dietary soy oil content and soy-derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice. Exp Dermatol 2003;12:30-36.
58. McElwee K, Freyschmidt-Paul P, Ziegler A, Happle R, Hoffmann R: Genetic susceptibility and severity of alopecia areata in human and animal models. Eur J Dermatol 2001;11:11-16.
59. Burnet FM: The Clonal Selection Theory of Acquired Immunity. London, Cambridge University Press, 1959.
60. Matzinger P: Tolerance, danger and the extended family. Annu Rev Immunol 1994;12:991-1045.
61. Theofilopoulos AN: The basis of autoimmunity. I. Mechanisms of aberrant self-recognition. Immunol Today 1995;16:90-98.
62. Theofilopoulos AN: The basis of autoimmunity. II. Genetic predisposition. Immunol Today 1995;16:150-159.
63. Wucherpfennig KW: Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 2001;108:1097-1104.
64. Ohashi PS: T-cell signalling and autoimmunity: Molecular mechanisms of disease. Nat Rev Immunol 2002;2:427-438.
65. Abbas AK, Lohr J, Knoechel B, Nagabhushanam V: T cell tolerance and autoimmunity. Autoimmun Rev 2004;3:471-475.
66. Whiting DA: Histopathologic features of alopecia areata: A new look. Arch Dermatol 2003;139:1555-1559.
67. Christoph T, Muller-Rover S, Audring H, Tobin DJ, Hermes B, Cotsarelis G, Ruckert R, Paus R: The human hair follicle immune system: Cellular composition and immune privilege. Br J Dermatol 2000;142:862-873.